Last reviewed · How we verify
BY101298 Capsules
At a glance
| Generic name | BY101298 Capsules |
|---|---|
| Sponsor | Chengdu Baiyu Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BY101298 Capsules CI brief — competitive landscape report
- BY101298 Capsules updates RSS · CI watch RSS
- Chengdu Baiyu Pharmaceutical Co., Ltd. portfolio CI